250 related articles for article (PubMed ID: 27311196)
1. [Ethical issues in genome-era].
Kosugi S
Nihon Rinsho; 2016 Jun; 74(6):1022-7. PubMed ID: 27311196
[TBL] [Abstract][Full Text] [Related]
2. Managing the ethical challenges of next-generation sequencing in genomic medicine.
Clarke AJ
Br Med Bull; 2014 Sep; 111(1):17-30. PubMed ID: 25122627
[TBL] [Abstract][Full Text] [Related]
3. Minimizing liability risks under the ACMG recommendations for reporting incidental findings in clinical exome and genome sequencing.
Evans BJ
Genet Med; 2013 Dec; 15(12):915-20. PubMed ID: 24030435
[TBL] [Abstract][Full Text] [Related]
4. The new genetics and informed consent: differentiating choice to preserve autonomy.
Bunnik EM; de Jong A; Nijsingh N; de Wert GM
Bioethics; 2013 Jul; 27(6):348-55. PubMed ID: 23718722
[TBL] [Abstract][Full Text] [Related]
5. Understanding variations in secondary findings reporting practices across U.S. genome sequencing laboratories.
Ackerman SL; Koenig BA
AJOB Empir Bioeth; 2018; 9(1):48-57. PubMed ID: 29131714
[TBL] [Abstract][Full Text] [Related]
6. Scanning the body, sequencing the genome: Dealing with unsolicited findings.
Wouters RHP; Cornelis C; Newson AJ; Bunnik EM; Bredenoord AL
Bioethics; 2017 Nov; 31(9):648-656. PubMed ID: 28975656
[TBL] [Abstract][Full Text] [Related]
7. Ethical issues raised by whole genome sequencing.
Pinxten W; Howard HC
Best Pract Res Clin Gastroenterol; 2014 Apr; 28(2):269-79. PubMed ID: 24810188
[TBL] [Abstract][Full Text] [Related]
8. Models of consent to return of incidental findings in genomic research.
Appelbaum PS; Parens E; Waldman CR; Klitzman R; Fyer A; Martinez J; Price WN; Chung WK
Hastings Cent Rep; 2014; 44(4):22-32. PubMed ID: 24919982
[TBL] [Abstract][Full Text] [Related]
9. On the justifiability of ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing.
May T
J Law Med Ethics; 2015; 43(1):134-42. PubMed ID: 25846044
[TBL] [Abstract][Full Text] [Related]
10. ACMG SF v3.1 list for reporting of secondary findings in clinical exome and genome sequencing: A policy statement of the American College of Medical Genetics and Genomics (ACMG).
Miller DT; Lee K; Abul-Husn NS; Amendola LM; Brothers K; Chung WK; Gollob MH; Gordon AS; Harrison SM; Hershberger RE; Klein TE; Richards CS; Stewart DR; Martin CL;
Genet Med; 2022 Jul; 24(7):1407-1414. PubMed ID: 35802134
[No Abstract] [Full Text] [Related]
11. ACMG SF v3.2 list for reporting of secondary findings in clinical exome and genome sequencing: A policy statement of the American College of Medical Genetics and Genomics (ACMG).
Miller DT; Lee K; Abul-Husn NS; Amendola LM; Brothers K; Chung WK; Gollob MH; Gordon AS; Harrison SM; Hershberger RE; Klein TE; Richards CS; Stewart DR; Martin CL;
Genet Med; 2023 Aug; 25(8):100866. PubMed ID: 37347242
[TBL] [Abstract][Full Text] [Related]
12. Have we asked too much of consent?
Koenig BA
Hastings Cent Rep; 2014; 44(4):33-4. PubMed ID: 25043364
[No Abstract] [Full Text] [Related]
13. Informed consent in direct-to-consumer personal genome testing: the outline of a model between specific and generic consent.
Bunnik EM; Janssens AC; Schermer MH
Bioethics; 2014 Sep; 28(7):343-51. PubMed ID: 23137034
[TBL] [Abstract][Full Text] [Related]
14. Consent to 'personal' genomics and privacy. Direct-to-consumer genetic tests and population genome research challenge traditional notions of privacy and consent.
Knoppers BM
EMBO Rep; 2010 Jun; 11(6):416-9. PubMed ID: 20448662
[TBL] [Abstract][Full Text] [Related]
15. Ethical conundrums in pediatric genomics.
Rotz SJ; Kodish E
Hematology Am Soc Hematol Educ Program; 2018 Nov; 2018(1):301-306. PubMed ID: 30504324
[TBL] [Abstract][Full Text] [Related]
16. Secondary findings from next generation sequencing: Psychological and ethical issues. Family and patient perspectives.
Houdayer F; Putois O; Babonneau ML; Chaumet H; Joly L; Juif C; Michon CC; Staraci S; Cretin E; Delanoue S; Charron P; Chassagne A; Edery P; Gautier E; Lapointe AS; Thauvin-Robinet C; Sanlaville D; Gargiulo M; Faivre L
Eur J Med Genet; 2019 Oct; 62(10):103711. PubMed ID: 31265899
[TBL] [Abstract][Full Text] [Related]
17. Misattributed parentage as an unanticipated finding during exome/genome sequencing: current clinical laboratory practices and an opportunity for standardization.
Eno C; Bayrak-Toydemir P; Bean L; Braxton A; Chao EC; El-Khechen D; Esplin ED; Friedman B; Hagman KDF; Hambuch T; Hernandez A; Juusola J; Londre G; Machado J; Mao R; Mighion L; Rehm HL; Ward P; Deignan JL
Genet Med; 2019 Apr; 21(4):861-866. PubMed ID: 30214068
[TBL] [Abstract][Full Text] [Related]
18. Next generation sequencing: considering the ethics.
Davey S
Int J Immunogenet; 2014 Dec; 41(6):457-62. PubMed ID: 25345691
[TBL] [Abstract][Full Text] [Related]
19. A pragmatic consideration of ethical issues relating to personal genomics.
Hsu AR; Mountain JL; Wojcicki A; Avey L
Am J Bioeth; 2009; 9(6-7):1-2. PubMed ID: 19998098
[No Abstract] [Full Text] [Related]
20. Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2021 update: a policy statement of the American College of Medical Genetics and Genomics (ACMG).
Miller DT; Lee K; Gordon AS; Amendola LM; Adelman K; Bale SJ; Chung WK; Gollob MH; Harrison SM; Herman GE; Hershberger RE; Klein TE; McKelvey K; Richards CS; Vlangos CN; Stewart DR; Watson MS; Martin CL;
Genet Med; 2021 Aug; 23(8):1391-1398. PubMed ID: 34012069
[No Abstract] [Full Text] [Related]
[Next] [New Search]
